Busulfan and Melphalan Conditioning in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Maintenance Therapy With Subcutaneous Bortezomib
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Optimized Retreatment and Prolonged Therapy With Bortezomib
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1
Acupuncture for Chemotherapy-induced Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- NA
CT Antigen TCR-Engineered T Cells for Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Status
- RECRUITING
- Phase
- N/A
Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
- Status
- COMPLETED
- Phase
- N/A
A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE4
89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
- Status
- COMPLETED
- Phase
- N/A
A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant
- Status
- COMPLETED
- Phase
- NA
IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3